scorecardresearch
Friday, August 1, 2025
TopicHCQ

Topic: HCQ

Not sure if HCQ works but adverse effects don’t seem to be a problem, say Indian doctors

The anti-malarial drug HCQ was left out of the WHO Solidarity trial and the USFDA emergency use list this week. Doctors in India say they don’t see any major side-effects from its use.

Story of 2 Indian-origin doctors behind one of the biggest medical research scandals in years

A selection of the best news reports, analysis and opinions published by ThePrint this week.

Divided by a virus — why the pandemic makes it look like nobody is in control in India

The pandemic debate is divided by ideology and BJP leaders are exploiting a grave crisis in political self-interest. The result of this conflict is now showing.

Why the HCQ-Trump-Lancet saga shouldn’t erode public trust in science

Science in the long haul is self-correcting, it never finds absolute truth, and it sometimes trips, but it can right itself and move on.

HCQ farce has tragic consequences as precious time studying treatments has been lost

The danger now is that if a severe flare-up in Covid infections were to strike, we would still lack clear evidence of any existing, cheap treatment.

‘Star’ cardiologist Mehra & data doctor Desai — story of Indian experts behind HCQ scandal

Mandeep R. Mehra, who graduated from a medical college in Maharashtra, is now a professor at Harvard, while Sapan S. Desai founded the data analytics firm Surgisphere.

The HCQ study mess: How 3 Indian researchers put reputation of Lancet, NEJM at stake

In episode 489 of #CutTheClutter, Shekhar Gupta discusses the controversial studies that were retracted after scientists around the world raised questions on its data accuracy.

HCQ doesn’t reduce risk of death among hospitalised Covid patients, says Oxford study

About 26% of patients in the trial getting the drug died, compared with about 24% receiving standard care, according to the University of Oxford.

Lancet withdraws controversial study linking HCQ to higher Covid death risk over data issues

Three of the four authors of the study apologised to The Lancet's editors and readership for any embarrassment or inconvenience their published findings may have caused.

On Camera

Trump tariff forces India to shed illusion. Stop conflating status with power

India’s future lies in pragmatism. Protectionism must be phased out gradually, not in disruptive shocks.

BJP MPs go full throttle against Trump even as govt hails enduring India-US ties amid tariff tension

New Delhi: While the Indian government has made a measured response to the 25 percent trade tariff imposed by Donald Trump, many in the BJP...

India to get last of Spain-built C-295 next month, focus now on 1st India-made aircraft

New Delhi: The last of the C-295 transport aircraft that is replacing the ageing Avro fleet of the Indian Air Force (IAF) will be...

Modi’s Bharat vs Indira’s India: 11-yr report card of politics, diplomacy, economy, nationalism

As Narendra Modi becomes India’s second-longest consecutively serving Prime Minister, we look at how he compares with Indira Gandhi across four key dimensions.